Serum concentrations and clinical effects of risperidone in schizophrenic patients in Singapore - A preliminary report [2]

British Journal of Clinical Pharmacology

Volumn 47, Issue 4, 1999, Pages 460-461

  Lee, H S ^a   Tan, C H ^a   Khoo, Y M ^a   Chee, K T ^a   Wong, K E ^a   Chong, S A ^a   Mahendran, R ^a   Yap, H L ^a   Low, B L ^a   Choo, C H ^a   Chan, A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGAPORE;

EID: 0032936460     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/bcp.1999.47.4.460     Document Type: Letter

References (4)